Event Announcement
The AI4Science Center is pleased to welcome Dr. Pranam Chatterjee, Assistant Professor of Biomedical Engineering and Computer Science at Duke University, for a special seminar on December 2nd. Dr. Chatterjee’s work integrates artificial intelligence, computational biology, and experimental design to develop new ways of engineering biological systems. The AI4Science Center will highlight current advances and emerging perspectives in machine learning for scientific discovery and showcase how AI-driven approaches are shaping the future of protein design, therapeutic development, and biological innovation. Attendees will have the opportunity to engage with cutting-edge research and explore how AI continues to transform scientific challenges into new discoveries.

Speaker Bio: Dr. Pranam Chatterjee
Dr. Pranam Chatterjee is an Assistant Professor of Biomedical Engineering and Computer Science at Duke University, where he leads the Programmable Biology Group. His research focuses on training generative language models to design novel proteins that bind to and edit target molecules. He previously completed his SB, SM, and PhD at MIT, where he developed sequence-based algorithms to engineer broad-targeting CRISPR enzymes capable of programmably binding and editing any DNA sequence.

Dr. Chatterjee’s lab pioneers deep learning–based approaches for discovering transcription factor proteins that direct stem cell differentiation, with a particular focus on ovarian cell types. His work also extends into the emerging field of proteome editing, where his team designs peptide-based tools to bind and modify previously undruggable proteins implicated in neurodegenerative diseases, viral infections, and pediatric cancers.

To translate his research into real-world solutions, Dr. Chatterjee has co-founded two biotechnology companies: UbiquiTx, Inc., focused on protein-based cancer therapeutics, and Gameto, Inc., which advances fertility and reproductive health solutions. He is the recipient of the Hartwell Individual Biomedical Research Award, along with multiple NIH and foundation awards recognizing the impact and innovation of his work.